Skip to main navigation Skip to search Skip to main content

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment

  • Fred Poordad
  • , Franco Felizarta
  • , Armen Asatryan
  • , Mark S. Sulkowski
  • , Robert W. Reindollar
  • , Charles S. Landis
  • , Stuart C. Gordon
  • , Steven L. Flamm
  • , Michael W. Fried
  • , David E. Bernstein
  • , Chih Wei Lin
  • , Ran Liu
  • , Sandra S. Lovell
  • , Teresa I. Ng
  • , Jens Kort
  • , Federico J. Mensa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science